The current state of amyloidosis therapeutics and the potential role of fluorine in their treatment
Open Access
- 1 November 2022
- journal article
- research article
- Published by Elsevier BV in Biochimie
- Vol. 202, 123-135
- https://doi.org/10.1016/j.biochi.2022.08.003
Abstract
No abstract availableKeywords
Funding Information
- Ministério da Ciência, Tecnologia e Ensino Superior (NORTE-01-0145-FEDER-000054)
- European Regional Development Fund (SFRH/BD/2020.04932)
- Fundação para a Ciência e a Tecnologia
This publication has 130 references indexed in Scilit:
- RNA toxicity in polyglutamine disorders: concepts, models, and progress of researchJournal of Molecular Medicine, 2013
- Protein aggregates in Huntington's diseaseExperimental Neurology, 2012
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin SynthesisNeuron, 2012
- Acetylation of Tau Inhibits Its Degradation and Contributes to TauopathyNeuron, 2010
- Strategies for the Inhibition of Protein Aggregation in Human DiseasesChemBioChem, 2010
- Novel RNA-based Strategies for Therapeutic Gene SilencingMolecular Therapy, 2010
- Glimpses of the molecular mechanisms of β2 -microglobulin fibril formation in vitro: Aggregation on a complex energy landscapeFEBS Letters, 2009
- Acetylation Targets Mutant Huntingtin to Autophagosomes for DegradationCell, 2009
- Design of an N-Methylated Peptide Inhibitor of α-Synuclein Aggregation Guided by Solid-State NMRJournal of the American Chemical Society, 2008
- Modulation of neurodegeneration by molecular chaperonesNature Reviews Neuroscience, 2005